Abstract
Prediction and validation of fetal exposure to dual BCRP/P-GP drug substrates using the proteomics informed efflux ratio-relative expression factor (ER-REF) approach and PBPK modeling and simulation
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have